Core Laboratories N.V.

Sümbol: CLB

NYSE

17.09

USD

Turuhind täna

  • 19.1648

    P/E suhe

  • -0.3545

    PEG suhe

  • 801.52M

    MRK Cap

  • 0.00%

    DIV tootlus

Core Laboratories N.V. (CLB) Finantsaruanded

Diagrammil näete Core Laboratories N.V. (CLB) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Bilanss

Sukeldudes Core Laboratories N.V. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

balance-sheet.row.cash-and-short-term-investments

015.115.417.7
13.8
11.1
13.1
14.4
14.8
22.5
23.4
25.1
19.2
29.3
133.9
181
36.1
25.6
54.2
13.7
16
16.8
14.9
14.5
12.9
18.1
8.2
10.5
2.9
4.3

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0123.1106.996.8
83.2
131.6
129.2
133.1
114.3
145.7
197.2
201.3
184.8
170.8
154.7
133.8
144.3
137.2
112.1
99.1
95.4
107.9
100.6
104.9
110.9
81.1
84.3
67.5
28
22.5

balance-sheet.row.inventory

071.760.445.4
38.2
50.2
45.7
33.3
33.7
40.9
43.4
46.8
49.3
53.2
34
32.2
34.8
29.4
30.2
29.1
29.4
31.4
34.5
41.1
34.1
24.5
18.9
12.5
9.5
8.1

balance-sheet.row.other-current-assets

013.228.929.1
30.7
28.4
43
26.6
23.6
29.5
37.9
30.6
43.6
27.5
26.7
43.5
26.8
28.5
29.1
11.3
10.7
10.9
25.7
18.9
17.3
16.7
15
7.2
2.2
1.5

balance-sheet.row.total-current-assets

0223.1211.7189.1
165.8
221.2
231
207.4
186.5
238.5
301.8
303.9
296.9
280.8
349.3
390.5
242
220.7
225.6
153.2
151.6
167
175.7
179.3
175.2
140.4
126.4
97.7
42.6
36.4

balance-sheet.row.property-plant-equipment-net

0153.5157.4172.3
181.7
199.2
122.9
123.1
129.9
143.2
149
138.8
125.4
115.3
104.2
98.8
103.5
93
87.7
81.3
79.6
94.8
95.5
97.6
83.3
64.5
68.2
53.6
27.7
20

balance-sheet.row.goodwill

099.499.499.4
99.4
213.4
219.4
179
179
178.2
164.5
163.3
163.3
162.8
154.2
148.6
148.6
138.8
132.6
0
0
140.1
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

06.97.58.1
8.6
17.4
13.1
9.4
9.9
10
10.6
10.9
8.7
8.2
8.7
6.5
7
7
6.6
139.3
139.7
150.3
142.4
151.3
147.9
150.3
149.5
82.8
8.4
8.5

balance-sheet.row.goodwill-and-intangible-assets

0106.4209.2219.5
221.1
354.2
294.9
254.3
256.7
243.5
224.8
218.3
214.2
171
162.9
155.1
155.6
145.8
139.2
139.3
139.7
150.3
142.4
151.3
147.9
150.3
149.5
82.8
8.4
8.5

balance-sheet.row.long-term-investments

04.84.54.2
4.1
4
3.8
3.6
3.2
2.7
2.3
1.9
1.9
0
0
-14.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

069.268.670.5
72.8
67.3
11.3
10.7
20.6
11.7
3.9
4.5
13.2
13.7
0
14.4
27.4
26
33
11.5
7.7
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

029.4-73-74.6
-76.9
-71.3
-15
-14.3
-23.8
-14.4
-6.2
-6.4
-15.1
24.4
19.6
13.7
9.1
19.2
15.7
9.2
10.2
9.3
7.7
11.3
4.1
5.9
4.5
3.9
1
0.4

balance-sheet.row.total-non-current-assets

0363.3366.7391.8
402.7
553.4
417.9
377.4
386.6
386.7
373.8
357.1
339.6
324.3
286.7
267.6
295.6
284.1
275.7
241.4
237.2
254.4
245.5
260.2
235.4
220.7
222.2
140.3
37.1
28.9

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0586.4578.4580.9
568.6
774.7
648.8
584.8
573.1
625.3
675.7
661
636.5
605.1
636
658.2
537.7
504.8
501.2
394.6
388.8
421.4
421.2
439.5
410.6
361.1
348.6
238
79.7
65.3

balance-sheet.row.account-payables

033.545.829.7
23
35.6
41.2
41.7
33.7
33.5
47.1
50.8
55.2
57.6
44.7
33
41.6
39.9
37.5
32.6
28.6
27.1
25.4
19.7
25.2
18.2
18.5
14.2
5.9
5.4

balance-sheet.row.short-term-debt

010.211.712.3
11.4
11.8
10.4
-17.1
-15.7
-14.1
-11
-10.9
0
2.3
147.5
23.6
0
3
2.8
2.5
3
3.4
1.1
0.5
0.9
1.7
18.6
3.5
4.4
2.7

balance-sheet.row.tax-payables

07.37.912.4
14.9
14.7
10.4
8.1
21.5
11.2
19.5
21.4
21.3
9.4
28.8
23.6
7.9
0
8.7
0
0
7.4
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0163.1210.7237.9
315.5
369.9
289.8
227
216.5
431
356
267
234
223.1
8.9
209.1
238.7
300
300
86.1
110.2
124.7
88
95.1
82
82.9
68.2
70.6
11.6
11.9

Deferred Revenue Non Current

030.531.8-24.3
-20.6
-27.3
1.4
-5.3
-6.3
-4.9
-7.2
-8.9
-6.8
24.1
21.2
16.9
8.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

039.739.640.9
49.8
50.8
33.7
63.3
70.3
87.3
84.8
85
71.4
58.3
66.9
33.3
54.1
46
41.8
31.2
33.2
28.3
21.8
16.6
25.4
27.2
24.1
24.4
7
6.1

balance-sheet.row.total-non-current-liabilities

0268.5286.3329.1
403.3
480.9
385.4
331.1
313.7
528.2
449.8
355.8
308.1
286
64.3
270
281.6
343.1
339
109.7
130
138.2
112.6
123.1
105.3
103.8
89.3
80.6
14.8
13.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

042.15061.6
67.5
76.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0356.6389.4419.9
493
592.5
487.9
436.1
417.8
649
581.7
491.6
448.6
423.5
343.7
376.4
377.3
441.2
427.9
179.3
197.4
199.9
162.7
163.1
156.9
150.9
150.5
122.7
32.1
28.1

balance-sheet.row.preferred-stock

0000
0
0
4.1
3.9
3.9
5.4
6.4
6.1
5.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

00.51.21.2
1.1
1.1
1.1
1.1
1.1
1.1
1.2
1.2
1.2
1.4
1.4
1.4
1.4
1.3
1.4
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0
0
0
0

balance-sheet.row.retained-earnings

0120.885.968.3
50.5
160.5
156.1
173.9
188
219.2
415.9
415.9
361.3
283.7
537
469.5
406.2
62.5
224.1
141.4
110.2
97.9
79.2
88.3
68.6
46.6
44.3
26.9
11.7
4.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-5-3.8-10.1
-7.2
-6.3
-5.5
-8.4
-9.8
-10.5
-11.9
-8.6
-8.4
-1.7
-6.2
0
-4.9
0.2
-2.1
-0.9
-2.5
-77.8
-64
-56.4
-45
-35.3
-19.8
-16.1
-8.1
-2.9

balance-sheet.row.other-total-stockholders-equity

0108.6105.6101.6
31.2
26.8
4.9
-21.8
-27.9
-238.9
-317.6
-245.2
-171.8
-105.4
-242.7
-191.5
-244.6
-1.9
-151.7
73.3
82.1
199.8
242.4
243.1
227.7
197.1
172.5
103.3
43.8
35.4

balance-sheet.row.total-stockholders-equity

0224.8189161
75.6
182.1
160.9
148.7
155.3
-23.7
94
169.4
187.9
177.9
289.5
279.4
158.2
62.1
71.8
214.3
190.3
220.4
258.1
275.6
251.9
208.9
197
114.1
47.4
37.1

balance-sheet.row.total-liabilities-and-stockholders-equity

0586.4578.4580.9
568.6
774.7
648.8
584.8
573.1
625.3
675.7
661
636.5
605.1
636
658.2
537.7
504.8
501.2
394.6
388.8
421.4
421.2
439.5
410.6
361.1
348.6
238
79.7
65.3

balance-sheet.row.minority-interest

054.74.6
4.1
4.3
4.1
3.9
3.9
5.4
6.4
6.1
5.7
3.8
2.8
2.4
2.2
1.5
1.4
1.1
1.1
1.1
0.3
0.8
1.9
1.3
1.1
1.2
0.2
0.1

balance-sheet.row.total-equity

0229.8193.7165.6
79.6
186.4
165
152.6
159.2
-18.3
100.4
175.5
193.6
181.7
292.3
281.8
160.3
63.6
73.3
215.3
191.4
221.5
258.5
276.4
253.7
210.2
198.1
115.3
47.6
37.2

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

04.84.54.2
4.1
4
3.8
3.6
3.2
2.7
2.3
1.9
1.9
0
0
-14.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

0215.4222.4250.3
327
381.8
289.8
227
216.5
431
356
267
234.1
225.4
156.4
209.1
238.7
303
302.8
88.6
113.2
128.1
89.2
95.6
82.9
84.6
86.8
74.1
16
14.6

balance-sheet.row.net-debt

0200.3207232.6
313.2
370.7
276.7
212.6
201.7
408.5
332.6
241.9
214.8
196.1
22.5
28.1
202.5
277.4
248.5
74.9
97.2
111.4
74.3
81.2
70
66.5
78.6
63.6
13.1
10.3

Rahavoogude aruanne

Core Laboratories N.V. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

cash-flows.row.net-income

036.719.720.2
-96.9
93.7
79.8
83.1
63.9
114.9
258.6
243.2
216.6
184.6
145.4
114.1
143.6
121.1
82.7
31.7
12.3
18.7
-9.1
20.6
19.2
3.4
20
15.4
7.7
5.1

cash-flows.row.depreciation-and-amortization

015.817.218.5
20.9
22.6
23.1
24.9
26.9
27.5
26.7
25.5
22.9
23.3
23.3
24.3
21.8
19.5
17.7
17.1
17.4
23.5
20.1
22.5
19.2
18.7
16.5
11
4.6
3.1

cash-flows.row.deferred-income-tax

0-10.80.46
-12.2
-36.3
1.8
9
-14.4
-0.1
4.7
6.8
3.6
-6.5
-10.1
25.6
-1.4
6.1
8.1
0.1
-2.7
-1.7
-1.8
0
-0.9
-1.8
-5.2
0
0
0

cash-flows.row.stock-based-compensation

0147.819.1
7.4
20.9
34.2
22.9
22.1
21.3
20.5
20.5
18.4
17.2
8.5
5.9
4.7
-9.6
-1.4
0
0
0
0
0
0
-0.6
3.8
0
0
0

cash-flows.row.change-in-working-capital

0-28.8-9.6-11.5
35.1
-10.8
-9.9
-9.4
35.2
47
-6.7
6.6
-23.4
-21
22.2
-2
-12.3
-17.2
6.8
8.1
3.4
12.1
9
-14.7
-29.6
-15.1
-28.9
-28.1
-4.1
-0.5

cash-flows.row.account-receivables

0-2.6-10.1-13.5
46.4
-3.2
2.3
-18.6
31.6
49.3
3.5
-16.3
-16.7
-12.1
-22.4
10
-5
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-13-14.9-4.5
1.5
-3.9
-10.4
0.4
6.2
3
2.9
1.3
3.2
-16
-2.4
1.8
-5.6
1
-4.1
-3
-0.9
4.1
6.6
-2.2
-9.3
-12
-2.8
-1.3
-0.9
1

cash-flows.row.account-payables

0-12.915.46.6
-12.8
-3.8
-1.8
8.7
-1
-13.4
-3
-6.3
-3.7
12
11.7
-17.5
2.8
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-0.300
0
0
0
0
-1.6
8
-10
27.9
-6.3
-4.9
35.3
-13.8
-1.7
-18.2
11
11.1
4.3
8
2.5
-12.5
-20.3
-3.1
-26.1
-26.8
-3.2
-1.5

cash-flows.row.other-non-cash-items

0-2.1-10.5-15.8
103.7
-0.5
-17.2
-6.3
-1.7
8.5
-0.4
-4.4
-0.9
6.6
16.6
13.9
-1.2
-3.8
5.1
17.9
23.8
8.2
22.7
-0.2
-0.6
-0.7
4.2
-0.2
0.6
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-10.6-10.2-13.5
-11.9
-22.3
-21.7
-18.8
-11.7
-24.3
-37.4
-38.9
-32.8
-30.1
-27.8
-17.5
-31.3
-24.1
-24.7
-19.1
-10.9
-23
-19.1
-29
-32.8
-19.1
-27
-15.3
-6.3
-2.3

cash-flows.row.acquisitions-net

00.50.20.9
1.5
3
-47.3
0
-1.2
-13.8
-1.2
-0.1
-0.9
-18.8
-9
0
-11.5
-7.3
0
0
-1.8
-13
-8
-12.8
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

00013.5
0
-1.9
-1.3
-2.1
-2.5
-2.9
-4.3
-6.6
-3.3
0
0
-1.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000.7
0
22.3
22.9
0
0
0
0
1.4
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.2
0

cash-flows.row.other-investing-activites

03.46.1-11.8
18.2
-6.8
-23.2
-18.5
-11
-22.9
-36.6
-37.9
-29.9
-33.2
-29.6
-16.9
-29.6
11.5
1.1
2.7
18.6
-0.2
1.8
1
4.4
29.1
9
-76.8
-4.3
-8

cash-flows.row.net-cash-used-for-investing-activites

0-6.7-3.9-10.2
7.9
-5.7
-70.6
-20.6
-14.7
-39.7
-42.1
-43.2
-34
-52
-38.6
-18.5
-41.1
-20
-23.6
-16.4
5.9
-36.1
-25.3
-40.8
-28.4
10
-18
-92.1
-10.4
-10.3

cash-flows.row.debt-repayment

0-10.3-131-226
-102
-123
-114
-130
-316.2
-139.7
-128.2
-134
-112.3
-348.6
-82.3
0
-61.4
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

0-4.1-0.460
56
138
178
140
197.2
215
217
167.1
121
417.7
0.3
0
6.2
18.5
71.4
8.2
8.5
1.5
0.6
3
3.1
1.9
1.7
0
0
0

cash-flows.row.common-stock-repurchased

0-2.2-3.9-8.3
-2.8
-3.3
-7.5
-16.9
-7.2
-159.7
-264.4
-227.2
-175.7
-61.8
-92.5
-9.4
-31.7
-181.8
-251.1
-41.4
-51.3
-58
-9
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-1.9-1.9-1.8
-12.4
-97.6
-97.3
-97.1
-95.1
-94.2
-89.1
-58.6
-53
-46
-40
-26.7
-27.6
0
0
0
0
0
0
0
0
0
0
0
0
-0.4

cash-flows.row.other-financing-activites

0-0.1113.8153.6
-1.8
0
-1.8
140
96.5
213.3
218.5
170.8
127.7
199.8
0.3
17.6
17.2
29
123.5
-27.5
-17.5
33.6
-6.8
11.5
11.9
-6.4
5.2
101.6
0
4.6

cash-flows.row.net-cash-used-provided-by-financing-activities

0-18.4-23.4-22.5
-63
-85.9
-42.5
-104.1
-124.9
-180.3
-263.1
-249.1
-213.3
-256.7
-214.4
-18.4
-103.6
-134.3
-56.2
-60.7
-60.3
-22.9
-15.2
14.5
15.1
-4.5
6.9
101.6
-0.4
4.2

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-0.3-2.33.9
2.7
-2
-1.3
-0.4
-7.7
-0.9
-1.7
5.9
-10.1
-104.5
-47.2
144.9
10.5
-28.6
40.5
-2.3
-0.2
1.9
0.4
1.9
-6.1
9.9
-4.5
7.6
-2
1.6

cash-flows.row.cash-at-end-of-period

015.115.417.7
13.8
11.1
13.1
14.4
14.8
22.5
23.4
25.1
19.2
29.3
133.9
181
36.1
25.6
54.2
13.7
16
16.8
14.9
14.5
12.9
18.1
8.2
10.5
2.9
4.3

cash-flows.row.cash-at-beginning-of-period

015.417.713.8
11.1
13.1
14.4
14.8
22.5
23.4
25.1
19.2
29.3
133.9
181
36.1
25.6
54.2
13.7
16
16.2
14.9
14.5
12.5
19
8.2
12.7
2.9
4.9
2.7

cash-flows.row.operating-cash-flow

024.82536.6
57.9
89.5
111.8
124.3
131.9
219.1
303.4
298.1
237.2
204.1
205.8
181.9
155.2
125.7
120.3
74.8
54.2
60.9
41
28.3
7.3
4.5
6.6
-1.9
8.8
7.7

cash-flows.row.capital-expenditure

0-10.6-10.2-13.5
-11.9
-22.3
-21.7
-18.8
-11.7
-24.3
-37.4
-38.9
-32.8
-30.1
-27.8
-17.5
-31.3
-24.1
-24.7
-19.1
-10.9
-23
-19.1
-29
-32.8
-19.1
-27
-15.3
-6.3
-2.3

cash-flows.row.free-cash-flow

014.214.723
46
67.3
90.1
105.5
120.2
194.8
266
259.2
204.4
174
178
164.3
123.9
101.6
95.6
55.7
43.3
37.9
21.8
-0.7
-25.6
-14.6
-20.4
-17.2
2.5
5.4

Kasumiaruande rida

Core Laboratories N.V. tulud muutusid võrreldes eelmise perioodiga NaN%. CLB brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

income-statement-row.row.total-revenue

0509.8489.7470.3
487.3
668.2
700.8
659.8
594.7
797.5
1085.2
1073.5
981.1
907.6
794.7
695.5
780.8
670.5
575.7
483.5
427.4
405.6
364.7
376.6
336.1
303.7
286.2
214.9
105.4
80.1

income-statement-row.row.cost-of-revenue

0415.7410.8386.4
395.6
518.2
520.1
499.2
469.5
560.1
692
688.4
644.7
593.4
513.8
457.8
514.8
449.2
407.1
368.1
336.4
326.9
301.3
293.3
268.7
245.4
220.5
170.5
84.7
64.2

income-statement-row.row.gross-profit

09478.983.8
91.6
150
180.8
160.6
125.2
237.4
393.3
385.1
336.3
314.3
280.9
237.8
266.1
221.3
168.6
115.3
91
78.7
63.4
83.3
67.4
58.3
65.7
44.4
20.7
15.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00-0.75.6
-1.8
-5.3
0.7
-0.5
0.3
-3.7
-1.1
0.3
4.1
22.4
20.9
20.6
28.5
3.7
12
16.6
16.4
22.6
22.5
27.8
19.2
18.7
16.5
11
4.6
3.1

income-statement-row.row.operating-expenses

040.337.444.2
34
48
62.9
47.7
39.4
49.7
45.7
52
43.2
63.5
53.9
51
60.2
37.5
45
54.4
44.5
45.4
42.7
43.7
32.8
31
24.9
17
8.2
5.8

income-statement-row.row.cost-and-expenses

0456448.2430.6
429.7
566.2
583
546.9
508.9
609.8
737.6
740.4
687.9
656.9
567.7
508.8
575
486.7
452.1
422.5
380.9
372.3
344
337
301.4
276.4
245.4
187.5
92.9
70

income-statement-row.row.interest-income

0011.69.2
14.4
14.7
0
0
0
0.1
0.4
0.8
0.3
0
0
0
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

013.411.69.2
14.4
14.7
13.3
10.7
11.6
12.4
10.6
9.3
8.8
10.9
15.8
15.5
6.4
0
0
0
0
7.9
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-13-11.6-9.2
-147
-14.7
0.7
-0.5
0.3
-26.6
-1.1
0.3
4.1
-1
-1.9
-15.5
8.3
14.6
5
-6.2
0.8
0.9
-2.4
-8.2
0.9
-14.4
-0.9
1.1
0.2
0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00-0.75.6
-1.8
-5.3
0.7
-0.5
0.3
-3.7
-1.1
0.3
4.1
22.4
20.9
20.6
28.5
3.7
12
16.6
16.4
22.6
22.5
27.8
19.2
18.7
16.5
11
4.6
3.1

income-statement-row.row.total-operating-expenses

0-13-11.6-9.2
-147
-14.7
0.7
-0.5
0.3
-26.6
-1.1
0.3
4.1
-1
-1.9
-15.5
8.3
14.6
5
-6.2
0.8
0.9
-2.4
-8.2
0.9
-14.4
-0.9
1.1
0.2
0.1

income-statement-row.row.interest-expense

013.411.69.2
14.4
14.7
13.3
10.7
11.6
12.4
10.6
9.3
8.8
10.9
15.8
15.5
6.4
0
0
0
0
7.9
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

015.817.218.5
20.9
22.6
23.1
24.9
26.9
27.5
26.7
25.5
22.9
23.3
23.3
24.3
21.8
19.5
17.7
17.1
17.4
23.5
20.1
22.5
19.2
18.7
16.5
11
4.6
3.1

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

053.841.545.3
55.8
96.7
118.6
112.4
86.2
161.1
346.5
333.4
297.3
250.8
226.9
186.8
206.7
183.8
123.6
60.9
46.5
33.3
20.8
36.6
34.7
27.3
40.8
27.4
12.5
10.1

income-statement-row.row.income-before-tax

040.83036.1
-91.2
82
105.3
101.7
74.6
148.7
335.9
324.1
288.5
238.8
209.1
171.3
208.6
181.3
117.8
46.6
38.2
25.6
13.2
28.7
27.4
5.1
33.7
22
11.4
7.3

income-statement-row.row.income-tax-expense

04.210.315.9
5.9
-12.3
25.4
18.6
10.7
33.8
77.3
80.9
71.8
54.2
63.7
57.2
65
60.2
35.1
14.9
10.2
6.9
5.5
8
8.2
1.7
10.1
6.6
3.7
2.2

income-statement-row.row.net-income

036.719.519.7
-97.1
102
79.5
83.1
63.9
114.8
257.5
242.8
216.1
184.7
144.9
113.6
143.6
121.1
82.7
31.2
12.3
18.7
-9.1
20.6
19.2
3.4
20
15.4
7.7
4.2

Korduma kippuv küsimus

Mis on Core Laboratories N.V. (CLB) koguvara?

Core Laboratories N.V. (CLB) koguvara on 586394999.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.181.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 0.469.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.082.

Mis on ettevõtte kogutulu?

Kogutulu on 0.112.

Mis on Core Laboratories N.V. (CLB) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 36674999.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 215384999.000.

Mis on tegevuskulude arv?

Tegevuskulud on 40258999.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.